Shopping Cart
- Remove All
- Your shopping cart is currently empty
Urtoxazumab (TMA-15) is a humanized monoclonal antibody that targets Shiga toxin 2 (Stx2) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Urtoxazumab (TMA-15) is a humanized monoclonal antibody that targets Shiga toxin 2 (Stx2) [1]. |
In vivo | Urtoxazumab (TMA-15) administered at a dosage ranging from 0.25 to 2.5 mg/kg via a single injection improves the lethality rate in B2F1 mice infected with [1] in a time- and dose-dependent manner. |
Alias | TMA-15, HuVTm1.1 |
Cas No. | 502496-16-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.